Mass General Brigham Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals

  • Investments
  • 82

  • Portfolio
  • 21

  • Exits
  • 27

Exits

Mass General Brigham Ventures General Information

Company Description

Founded in 2008, Mass General Brigham Ventures is a venture capital investment firm based in Somerville, Massachusetts. The firm seeks to invest in healthcare sector companies that develop products across a range of categories including drugs, devices, diagnostics, and digital health. This firm is a Registered Investment Adviser (RIA).

Business Details

Formerly Known As
PIF, Partners Innovation Fund
Year Founded
2008
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 399 Revolution Drive
  • Suite 999
  • Somerville, MA 02145
  • United States
+1 (857)

Mass General Brigham Ventures Investments (82)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Abcuro 07-Feb-2025 Later Stage VC Drug Discovery Clinical Trials - Phase 2
Rippl Care 01-Oct-2024 Elder and Disabled Care Generating Revenue
Tuesday Health 21-May-2024 Clinics/Outpatient Services Generating Revenue
Nocion Therapeutics 14-Mar-2024 Drug Discovery Clinical Trials - Phase 2
InStride Health 23-Feb-2024 Clinics/Outpatient Services Generating Revenue
Claris Bio 04-Jan-2024 Drug Discovery Clinical Trials - Phase 3
Mediar Therapeutics 11-Sep-2023 Drug Discovery Clinical Trials - Phase 1
ROME Therapeutics 14-Aug-2023 Drug Discovery Pre-Clinical Trials
Abcuro 11-Aug-2023 Later Stage VC Drug Discovery Clinical Trials - Phase 2
Violet Therapeutics 31-May-2023 Seed Round Drug Discovery Generating Revenue
You’re viewing 10 of 82 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mass General Brigham Ventures Exits (27)

Company Name Exit Date Exit Type Exit Size
Lyndra Therapeutics 25-Mar-2025 Out of Business
SeQure DX 29-Jan-2025
Amolyt Pharma 15-Jul-2024
SwanBio Therapeutics 25-Jun-2024
AKUOS 01-May-2024
Paros Bio 01-Sep-2023
Triplet Therapeutics 12-Oct-2022
Life Image 15-Sep-2022
Albamunity 08-Jul-2021 Out of Business
Verve Therapeutics 17-Jun-2021 IPO
You’re viewing 10 of 27 exits. Get the full list »

Mass General Brigham Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Mass General Brigham Ventures Co-Investors (149)

Name With Exits Lead Partner Series Industry
Casdin Capital 4 Series chart Industry bar
GV Series chart Industry bar
Mission BioCapital Series chart Industry bar
OrbiMed Series chart Industry bar
RA Capital Management Series chart Industry bar
You’re viewing 5 of 149 co-investors. Get the full list »

Mass General Brigham Ventures FAQs

  • What is Mass General Brigham Ventures?

    Founded in 2008, Mass General Brigham Ventures is a venture capital investment firm based in Somerville, Massachusetts.

  • When was Mass General Brigham Ventures founded?

    Mass General Brigham Ventures was founded in 2008.

  • Where is Mass General Brigham Ventures headquartered?

    Mass General Brigham Ventures is headquartered in Somerville, MA.

  • How many investments has Mass General Brigham Ventures made?

    Mass General Brigham Ventures has made 82 investments.

  • What has Mass General Brigham Ventures invested in?

    Mass General Brigham Ventures has made numerous investments in companies like Abcuro, Rippl Care, and Tuesday Health within the Drug Discovery, Elder and Disabled Care, and Clinics/Outpatient Services industries.

  • What has Mass General Brigham Ventures invested in recently?

    Mass General Brigham Ventures's latest investment was on 07-Feb-2025 in Abcuro, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »